Human Immunodeficiency Virus Controllers: Mechanisms of Durable Virus Control in the Absence of Antiretroviral Therapy, Immunity, vol.27, issue.3, pp.406-416, 2007. ,
DOI : 10.1016/j.immuni.2007.08.010
HIV Controllers: A Homogeneous Group of HIV-1--Infected Patients with Spontaneous Control of Viral Replication, Clinical Infectious Diseases, vol.41, issue.7, pp.1053-1056, 2005. ,
DOI : 10.1086/433188
HIV controllers: a genetically determined or inducible phenotype?, Immunological Reviews, vol.473, issue.1, pp.281-294, 2013. ,
DOI : 10.1111/imr.12076
Genotype on AIDS, Annual Review of Medicine, vol.54, issue.1, pp.535-551, 2003. ,
DOI : 10.1146/annurev.med.54.101601.152346
Immunogenetics of Spontaneous Control of HIV, Annual Review of Medicine, vol.63, issue.1, pp.131-145, 2012. ,
DOI : 10.1146/annurev-med-062909-130018
HIV and HLA Class I: An Evolving Relationship, Immunity, vol.37, issue.3, pp.426-440, 2012. ,
DOI : 10.1016/j.immuni.2012.09.005
URL : http://doi.org/10.1016/j.immuni.2012.09.005
Mamu-B*08-Positive Macaques Control Simian Immunodeficiency Virus Replication, Journal of Virology, vol.81, issue.16, pp.8827-8832, 2007. ,
DOI : 10.1128/JVI.00895-07
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1951344
The High-Frequency Major Histocompatibility Complex Class I Allele Mamu-B*17 Is Associated with Control of Simian Immunodeficiency Virus SIVmac239 Replication, Journal of Virology, vol.80, issue.10, pp.5074-5077, 2006. ,
DOI : 10.1128/JVI.80.10.5074-5077.2006
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells, Blood, vol.107, issue.12, pp.4781-4789, 2006. ,
DOI : 10.1182/blood-2005-12-4818
HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors, Nature Immunology, vol.3, issue.11, pp.1061-1068, 2002. ,
DOI : 10.1038/ni845
Lytic Granule Loading of CD8+ T Cells Is Required for HIV-Infected Cell Elimination Associated with Immune Control, Immunity, vol.29, issue.6, 2008. ,
DOI : 10.1016/j.immuni.2008.10.010
Differential Neutralization of Human Immunodeficiency Virus (HIV) Replication in Autologous CD4 T Cells by HIV-Specific Cytotoxic T Lymphocytes, Journal of Virology, vol.83, issue.7, pp.3138-3149, 2009. ,
DOI : 10.1128/JVI.02073-08
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype, Proceedings of the National Academy of Sciences, vol.104, issue.16, pp.6776-6781, 2007. ,
DOI : 10.1073/pnas.0611244104
CD8+ T Cells Specific for EBV, Cytomegalovirus, and Influenza Virus Are Activated during Primary HIV Infection, The Journal of Immunology, vol.173, issue.4, pp.2410-2418, 1950. ,
DOI : 10.4049/jimmunol.173.4.2410
Heterogeneity in HIV Suppression by CD8 T Cells from HIV Controllers: Association with Gag-Specific CD8 T Cell Responses, The Journal of Immunology, vol.182, issue.12, pp.7828-7837, 1950. ,
DOI : 10.4049/jimmunol.0803928
VACCINES: EFFECTOR AND MEMORY T-CELL DIFFERENTIATION: IMPLICATIONS FOR VACCINE DEVELOPMENT, Nature Reviews Immunology, vol.166, issue.4, pp.251-262, 2002. ,
DOI : 10.1046/j.1365-2249.2001.01600.x
Immune Exhaustion Occurs Concomitantly With Immune Activation and Decrease in Regulatory T Cells in Viremic Chronically HIV-1???Infected Patients, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.54, issue.5, pp.447-454, 2010. ,
DOI : 10.1097/QAI.0b013e3181e0c7d0
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction, Nature Medicine, vol.168, issue.10, pp.1198-1202, 2006. ,
DOI : 10.1038/nm1482
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load, Blood, vol.104, issue.4, pp.942-947, 2004. ,
DOI : 10.1182/blood-2003-09-3333
Ex vivo T cell???based HIV suppression assay to evaluate HIV-specific CD8+ T-cell responses, Nature Protocols, vol.178, issue.6, pp.1033-1041, 2010. ,
DOI : 10.1038/nprot.2006.268
Both HLA-B*57 and Plasma HIV RNA Levels Contribute to the HIV-Specific CD8+ T Cell Response in HIV Controllers, Journal of Virology, vol.88, issue.1, pp.176-187, 2014. ,
DOI : 10.1128/JVI.02098-13
Interferon-Alpha Administration Enhances CD8+ T Cell Activation in HIV Infection, PLoS ONE, vol.24, issue.5, 2012. ,
DOI : 10.1371/journal.pone.0030306.t002
URL : http://doi.org/10.1371/journal.pone.0030306
Effects of IFN-?? as a signal-3 cytokine on human na??ve and antigen-experienced CD8+ T cells, European Journal of Immunology, vol.89, issue.12, pp.3389-3402, 2010. ,
DOI : 10.1002/eji.201040664
A Role for CD40 Expression on CD8+ T Cells in the Generation of CD8+ T Cell Memory, Science, vol.297, issue.5589, pp.2060-2063, 2002. ,
DOI : 10.1126/science.1072615
Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation, AID-CYTO9.3.0.CO, pp.71-762, 1997. ,
DOI : 10.1002/(SICI)1097-0320(19970101)27:1<71::AID-CYTO9>3.0.CO;2-O
Human CD8+ T cells expressing HLA-DR and CD28 show telomerase activity and are distinct from cytolytic effector T cells, European Journal of Immunology, vol.1, issue.2, pp.459-466, 2001. ,
DOI : 10.1002/1521-4141(200102)31:2<459::AID-IMMU459>3.0.CO;2-Y
T cells expanded in HIV-1 infection are qualitatively identical to those from healthy controls, European Journal of Immunology, vol.97, issue.10, pp.2608-2620, 2012. ,
DOI : 10.1002/eji.201142046
Inhibitory Potential of Subpopulations of CD8+ T Cells in HIV-1-Infected Elite Suppressors, Journal of Virology, vol.86, issue.24, pp.13679-13688, 2012. ,
DOI : 10.1128/JVI.02439-12
CD38 is expressed selectively during the activation of a subset of mature T cells with reduced proliferation but improved potential to produce cytokines, Journal of Leukocyte Biology, vol.77, issue.4, pp.513-521, 2005. ,
DOI : 10.1189/jlb.0404262
Elite Controllers with Low to Absent Effector CD8+ T Cell Responses Maintain Highly Functional, Broadly Directed Central Memory Responses, Journal of Virology, vol.86, issue.12, pp.6959-6969, 2012. ,
DOI : 10.1128/JVI.00531-12
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3393560
Nonpathogenesis of Simian Immunodeficiency Virus Infection Is Associated with Reduced Inflammation and Recruitment of Plasmacytoid Dendritic Cells to Lymph Nodes, Not to Lack of an Interferon Type I Response, during the Acute Phase, Journal of Virology, vol.84, issue.4, pp.1838-1846, 2010. ,
DOI : 10.1128/JVI.01496-09
Plasmacytoid Dendritic Cells (pDCs) From HIV Controllers Produce Interferon-?? and Differentiate Into Functional Killer pDCs Under HIV Activation, Journal of Infectious Diseases, vol.206, issue.5, pp.790-801, 2012. ,
DOI : 10.1093/infdis/jis384
URL : http://jid.oxfordjournals.org/cgi/content/short/206/5/790
HIV-1 immunopathogenesis: How good interferon turns bad, Clinical Immunology, vol.123, issue.2, pp.121-128, 2007. ,
DOI : 10.1016/j.clim.2006.09.016
URL : https://hal.archives-ouvertes.fr/hal-00110852
Differential expression of IFN-?? and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients, Proceedings of the National Academy of Sciences, vol.103, issue.18, pp.7000-7005, 2006. ,
DOI : 10.1073/pnas.0600363103
Tight Regulation of Memory CD8+ T Cells Limits Their Effectiveness during Sustained High Viral Load, Immunity, vol.35, issue.2, pp.285-298, 2011. ,
DOI : 10.1016/j.immuni.2011.05.017
The Functional Profile of Primary Human Antiviral CD8+ T Cell Effector Activity Is Dictated by Cognate Peptide Concentration, The Journal of Immunology, vol.172, issue.10, pp.6407-6417, 1950. ,
DOI : 10.4049/jimmunol.172.10.6407
Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor, Nature Medicine, vol.15, issue.12, pp.1390-1395, 2008. ,
DOI : 10.1038/nm.1779
Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity, Blood, vol.113, issue.25, pp.6351-6360, 2009. ,
DOI : 10.1182/blood-2009-02-206557
URL : https://hal.archives-ouvertes.fr/inserm-00668485
High-Functional-Avidity Cytotoxic T Lymphocyte Responses to HLA-B-Restricted Gag-Derived Epitopes Associated with Relative HIV Control, Journal of Virology, vol.85, issue.18, pp.9334-9345, 2011. ,
DOI : 10.1128/JVI.00460-11
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165743
T cells is reflected by their avidity, polyfunctionality, and clonal turnover, The Journal of Experimental Medicine, vol.93, issue.10, pp.2473-2485, 2007. ,
DOI : 10.1016/S0022-1759(02)00195-3
Perforin Expression Directly Ex Vivo by HIV-Specific CD8+ T-Cells Is a Correlate of HIV Elite Control, PLoS Pathogens, vol.16, issue.5, 2010. ,
DOI : 10.1371/journal.ppat.1000917.s014
Predictive Value of Immunologic and Virologic Markers After Long or Short Duration of HIV-1 Infection, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.29, issue.4, pp.346-355, 1999. ,
DOI : 10.1097/00126334-200204010-00004
T Cell Count in HIV???Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of Therapy, The Journal of Infectious Diseases, vol.197, issue.1, pp.126-133, 2008. ,
DOI : 10.1086/524143
Persistent Low???Level Viremia in HIV???1 Elite Controllers and Relationship to Immunologic Parameters, The Journal of Infectious Diseases, vol.200, issue.6, pp.984-990, 2009. ,
DOI : 10.1086/605446
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725728
Microbial translocation is a cause of systemic immune activation in chronic HIV infection, Nature Medicine, vol.174, issue.12, pp.1365-1371, 1511. ,
DOI : 10.1038/nm1511
CD4 Dynamics over a 15 Year-Period among HIV Controllers Enrolled in the ANRS French Observatory, PLoS ONE, vol.4, issue.9, 2011. ,
DOI : 10.1371/journal.pone.0018726.t002
URL : https://hal.archives-ouvertes.fr/pasteur-01420582
Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long???Term Nonprogressors in the US Department of Defense HIV Natural History Study, The Journal of Infectious Diseases, vol.200, issue.11, pp.1714-1723, 2009. ,
DOI : 10.1086/646609
Cd8+ Lymphocyte Activation At Human Immunodeficiency Virus Type 1 Seroconversion: Development Of Hla-Dr+ Cd38- Cd8+ Cells Is Associated With Subsequent Stable Cd4+ Cell Levels, Journal of Infectious Diseases, vol.170, issue.4, pp.775-781, 1994. ,
DOI : 10.1093/infdis/170.4.775